Literature DB >> 10074494

Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome.

H Furukawa1, S Murata, T Yabe, N Shimbara, N Keicho, K Kashiwase, K Watanabe, Y Ishikawa, T Akaza, K Tadokoro, S Tohma, T Inoue, K Tokunaga, K Yamamoto, K Tanaka, T Juji.   

Abstract

Expression of histocompatibility leukocyte antigen (HLA) class I molecules on the cell surface depends on the heterodimer of the transporter associated with antigen processing 1 and 2 (TAP1 and TAP2), which transport peptides cleaved by proteasome to the class I molecules. Defects in the TAP2 protein have been reported in two families with HLA class I deficiency, the so-called bare lymphocyte syndrome (BLS) type I. We have, to our knowledge, identified for the first time a splice site mutation in the TAP1 gene of another BLS patient. In addition, class I heavy chains (HCs) did not form the normal complex with tapasin in the endoplasmic reticulum (ER) of the cells of our patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074494      PMCID: PMC408126          DOI: 10.1172/JCI5335

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.

Authors:  B Ortmann; J Copeman; P J Lehner; B Sadasivan; J A Herberg; A G Grandea; S R Riddell; R Tampé; T Spies; J Trowsdale; P Cresswell
Journal:  Science       Date:  1997-08-29       Impact factor: 47.728

2.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells.

Authors:  L Van Kaer; P G Ashton-Rickardt; H L Ploegh; S Tonegawa
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

3.  A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.

Authors:  H Teisserenc; W Schmitt; N Blake; R Dunbar; S Gadola; W L Gross; A Exley; V Cerundolo
Journal:  Immunol Lett       Date:  1997-06-01       Impact factor: 3.685

Review 4.  Protein degradation: the ins and outs of the matter.

Authors:  P Cresswell; E A Hughes
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

5.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

Authors:  M B Shapiro; P Senapathy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

6.  The bare-lymphocyte syndrome: report on the registry.

Authors:  J L Touraine
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

7.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP.

Authors:  B Sadasivan; P J Lehner; B Ortmann; T Spies; P Cresswell
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

8.  A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer.

Authors:  H L Chen; D Gabrilovich; R Tampé; K R Girgis; S Nadaf; D P Carbone
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

9.  Homozygous human TAP peptide transporter mutation in HLA class I deficiency.

Authors:  H de la Salle; D Hanau; D Fricker; A Urlacher; A Kelly; J Salamero; S H Powis; L Donato; H Bausinger; M Laforet
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

10.  Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma.

Authors:  H Hisamatsu; N Shimbara; Y Saito; P Kristensen; K B Hendil; T Fujiwara; E Takahashi; N Tanahashi; T Tamura; A Ichihara; K Tanaka
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  11 in total

1.  Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome.

Authors:  M Raghavan
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 2.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.

Authors:  Jonathan C Sanford; Hong Wu; Yasmina Abdiche; Julie A Harney; Javier Chaparro-Riggers; Karissa Adkins
Journal:  Immunogenetics       Date:  2017-02-03       Impact factor: 2.846

4.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.

Authors:  E W Hewitt; S S Gupta; P J Lehner
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 5.  Insights into NK cell biology from human genetics and disease associations.

Authors:  Stephanie M Wood; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Cell Mol Life Sci       Date:  2011-08-27       Impact factor: 9.261

Review 6.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

7.  Characterization and allelic variation of the transporters associated with antigen processing (TAP) genes in the domestic dog (Canis lupus familiaris).

Authors:  Gregory S Gojanovich; Peter Ross; Savannah G Holmer; Jennifer C Holmes; Paul R Hess
Journal:  Dev Comp Immunol       Date:  2013-07-25       Impact factor: 3.636

8.  Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization.

Authors:  Ralf M Leonhardt; Parwiz Abrahimi; Susan M Mitchell; Peter Cresswell
Journal:  J Immunol       Date:  2014-02-05       Impact factor: 5.422

9.  The genetic basis of severe combined immunodeficiency and its variants.

Authors:  Diana Tasher; Ilan Dalal
Journal:  Appl Clin Genet       Date:  2012-08-07

10.  Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.

Authors:  Jacques Zimmer; Huguette Bausinger; Emmanuel Andrès; Lionel Donato; Daniel Hanau; François Hentges; Alessandro Moretta; Henri de la Salle
Journal:  PLoS One       Date:  2007-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.